News
DST initiates study to identify biomarkers to predict progression from non-severe to severe COVID 19 cases
The approach is to differentiate between the mild and severe cases of COVID-19 based on the determination of biomarkers from detailed metabolome or proteome investigations.
AstraZeneca initiates CALAVI clinical trial withanti-blood cancer drug Calquence against COVID-19
The trial design is based upon strong scientific evidence supporting the role of the Bruton’s tyrosine kinase (BTK) pathway in the production of inflammatory cytokines and on encouraging early clinical data.
